Skip to content

Member

Roberta METSOLA

EPP · Malta

Group
EPP PPE
Country
Malta
Roll-call participation
0.0 %ⓘ of 5 928 roll calls in office · chamber median 90.2 % · whole term, roll calls No vote recorded while in office in this period (not the same as absent: chairing the sittings, as the President does, looks the same).
With majority line
no votesⓘ
More facts (4)
National party
PN Partit Nazzjonalista
In office
Since 16 Jul 2024
Against clear line
no votesⓘ
Member id
118859
More

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

No vote recorded while in office in this period (not the same as absent: chairing the sittings, as the President does, looks the same).

Roll-call participation ⓘ

0.0 %

0 of 5 928 roll calls while in office

Chamber median: 90.2 %

With majority line ⓘ

no votes

no votes where their group had a line in the period

Against clear line ⓘ

no votes

no votes where their group had a clear line in the period

Abstention ⓘ

no votes

no votes cast in the period

  • Whole term, 5 928 roll-call votes.
  • “No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
  • A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 5 928

Export

Every roll-call vote of the term with the member’s position, newest first.

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
DateDecision and voteResultPositionMajority line
9 Sept 2025EU-Kyrgyz Republic Enhanced Partnership and Cooperation Agreement (Resolution) Final vote — text as a wholeAdopted 434 for, 49 against, 168 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025EU-Kyrgyz Republic Enhanced Partnership and Cooperation Agreement (Resolution) Amendment 12, adding text after paragraph 12 72 for, 522 against, 51 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025EU-Kyrgyz Republic Enhanced Partnership and Cooperation Agreement Final vote on the draft Council decisionConsent given 473 for, 114 against, 58 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025EU-Brazil Agreement: cooperation with and through Europol and the Federal Police of Brazil Final vote on the draft Council decisionConsent given 606 for, 5 against, 19 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Final votePassed 431 for, 145 against, 76 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 395 to recital 19 187 for, 442 against, 16 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendments 409 + 417 (voted as one) to Annex VII, Part C, point 16 208 for, 431 against, 7 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 371 to Annex VII, Part C, point 13 530 for, 112 against, 4 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendments 408 + 416 (voted as one) to Annex VII, Part C, point 6 204 for, 438 against, 8 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 407 to Annex VII, Part C, point 4 137 for, 447 against, 61 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 318 to Article 55, après le paragraph 2 512 for, 120 against, 14 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 390 to Article 55, après le paragraph 2 105 for, 538 against, 3 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 389 to Article 38, paragraph 3, après le point b 96 for, 549 against, 3 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 388 to Article 18, paragraph 1 124 for, 515 against, 7 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 387 to Article 7, après le paragraph 4 207 for, 431 against, 10 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 137 to Article 6, paragraph 3, alinéa 1 — part 2 451 for, 182 against, 10 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 137 to Article 6, paragraph 3, alinéa 1 — part 1 461 for, 185 against, 5 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 394 to Article 6, paragraph 1, après l'alinéa 2 142 for, 496 against, 8 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 403 to Article 6, paragraph 1, alinéa 2 192 for, 442 against, 11 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 130 to Article 6, paragraph 1, alinéa 1 444 for, 189 against, 14 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 402 to Article 6, paragraph 1, alinéa 1 194 for, 434 against, 15 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 393 to Article 6, paragraph 1, alinéa 1 120 for, 529 against, 2 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 150 to Article 6 — part 2 438 for, 196 against, 8 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 150 to Article 6 — part 1 452 for, 195 against, 2 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 134 to Article 6 473 for, 154 against, 22 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 133 to Article 6 — part 2 512 for, 122 against, 15 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 133 to Article 6 — part 1 505 for, 126 against, 19 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 401 to Article 6 131 for, 447 against, 72 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 392 to Article 4, après le paragraph 1 138 for, 504 against, 4 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 391 to Article 4, paragraph 1, après le point b 138 for, 508 against, 2 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendments 399 + 412 (voted as one) to Article 3, paragraph 1, point 15 168 for, 445 against, 36 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 398 to Article 3, paragraph 1, après le point 9 199 for, 437 against, 11 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 397 to Article 3, paragraph 1, point 9 158 for, 471 against, 17 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 396 to Article 2, paragraph 6, partie introductive 197 for, 418 against, 30 abstainedPosition: No vote recorded Majority line: Against
8 Sept 2025Wednesday’s agenda – Request by the PPE Group Ordre du jour de mercredi — Demande du groupe PPE 384 for, 10 against, 51 abstainedPosition: No vote recorded Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Final vote — text as a wholeAdopted 523 for, 75 against, 14 abstainedPosition: No vote recorded Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 1 to paragraph 14 157 for, 428 against, 36 abstainedPosition: No vote recorded Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 8, adding text after paragraph 13 95 for, 420 against, 119 abstainedPosition: No vote recorded Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Paragraph 13 — part 2 483 for, 84 against, 67 abstainedPosition: No vote recorded Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 7 to paragraph 13 80 for, 407 against, 151 abstainedPosition: No vote recorded Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 6, adding text after paragraph 12 79 for, 531 against, 18 abstainedPosition: No vote recorded Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 5 to paragraph 10 47 for, 560 against, 27 abstainedPosition: No vote recorded Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 4 to paragraph 8 88 for, 520 against, 22 abstainedPosition: No vote recorded Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 3, adding text after paragraph 2 63 for, 552 against, 15 abstainedPosition: No vote recorded Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 2, adding text after paragraph 1 123 for, 390 against, 110 abstainedPosition: No vote recorded Majority line: Against
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Final vote — text as a wholeAdopted 494 for, 83 against, 71 abstainedPosition: No vote recorded Majority line: For
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Amendment 2, adding text after recital S 217 for, 409 against, 23 abstainedPosition: No vote recorded Majority line: Against
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Amendment 1, adding text after citation 2 226 for, 409 against, 17 abstainedPosition: No vote recorded Majority line: Against
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Paragraph 34 — part 2 566 for, 60 against, 23 abstainedPosition: No vote recorded Majority line: For
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Paragraph 32 — part 1 588 for, 56 against, 7 abstainedPosition: No vote recorded Majority line: For

Show all 50 votes on this page

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 107 of 107 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table
Roll calls held at each sitting while in office and how many of them the member voted in.
SittingRoll callsVoted in
17 Jul 2024230
18 Jul 202410
16 Sept 202420
18 Sept 202420
19 Sept 2024920
7 Oct 202420
8 Oct 202410
9 Oct 2024180
10 Oct 202440
21 Oct 202420
22 Oct 2024100
23 Oct 20241290
24 Oct 2024130
13 Nov 202420
14 Nov 2024360
25 Nov 202420
26 Nov 2024180
27 Nov 2024110
28 Nov 2024570
17 Dec 2024130
18 Dec 2024330
19 Dec 2024450
20 Jan 202520
21 Jan 202510
22 Jan 202520
23 Jan 2025450
10 Feb 202510
11 Feb 2025320
12 Feb 2025100
13 Feb 2025300
10 Mar 202520
11 Mar 202590
12 Mar 20252280
13 Mar 2025240
31 Mar 202530
1 Apr 2025350
2 Apr 20252510
3 Apr 2025620
5 May 202550
6 May 2025100
7 May 20252200
8 May 20251030
21 May 202520
22 May 2025530
16 Jun 202520
17 Jun 2025410
18 Jun 2025910
19 Jun 2025870
7 Jul 202510
8 Jul 2025550
9 Jul 20251340
10 Jul 2025360
8 Sept 202510
9 Sept 20251010
10 Sept 2025340
11 Sept 2025690
6 Oct 202520
7 Oct 202550
8 Oct 2025550
9 Oct 2025650
20 Oct 202530
21 Oct 2025130
22 Oct 20251860
23 Oct 2025550
13 Nov 20252670
24 Nov 202530
25 Nov 2025750
26 Nov 20251000
27 Nov 20251250
15 Dec 202540
16 Dec 2025660
17 Dec 2025430
18 Dec 2025420
20 Jan 2026670
21 Jan 20261120
22 Jan 2026580
9 Feb 202620
10 Feb 2026380
11 Feb 2026130
12 Feb 20261410
24 Feb 2026430
9 Mar 202610
10 Mar 20261970
11 Mar 2026600
12 Mar 2026340
25 Mar 202630
26 Mar 2026690
27 Apr 202620
28 Apr 20262250
29 Apr 20262960
30 Apr 2026680
18 May 202640
19 May 202630
20 May 2026960
21 May 2026980
15 Jun 202620
16 Jun 2026400
17 Jun 20261270
18 Jun 2026770
6 Jul 202620
7 Jul 2026720
8 Jul 20261440
9 Jul 2026670
14 Sept 202610
15 Sept 20261550
16 Sept 2026800
17 Sept 20261240

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within EPP

No member meets the rule within the group.

Outside the group

No member meets the rule outside the group.

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
BodyRoleFromTo
Delegation to the Parliamentary Assembly of the Union for the MediterraneanDMED Parliamentary assemblyChair3 Oct 2024now
Committee on the Environment, Public Health and Food SafetyENVI CommitteeMember19 Jul 202415 Sept 2024
Committee on Industry, Research and EnergyITRE CommitteeSubstitute19 Jul 20248 Sept 2024

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
DossierRoleCommitteeDate
EP delegation to the Conciliation Committee on Air Passenger Rights 2013/0072(COD)Trilogue negotiator18 Feb 2026

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

1 161 contributions recorded; 1 608 minutes of speaking time.

Date: the sitting. Debate: the item debated, and the group when they spoke on its behalf. Kind: speech or written statement, with speaking time. Verbatim: the verbatim report on Parliament’s site.
DateDebateKindVerbatim
17 Sept 2026Formal sitting – Address by Mark Carney, Prime Minister of Canada Speech · 3 minRead
16 Sept 2026State of the Union (debate) SpeechRead
16 Sept 2026State of the Union (debate) SpeechRead
16 Sept 2026State of the Union (debate) Speech · 3 minRead
14 Sept 2026Council positions at first reading (Rule 64) SpeechRead
14 Sept 2026Council positions at first reading (Rule 64) SpeechRead
14 Sept 2026Council positions at first reading (Rule 64) SpeechRead
14 Sept 2026Council positions at first reading (Rule 64) SpeechRead
14 Sept 2026Order of business Speech · 1 minRead
14 Sept 2026Order of business Speech · 1 minRead

Show all 40 recent contributions

Questions and motions, 0

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

No question or motion recorded this term.

Amendments tabled in committee, 0

Committee amendment documents that carry amendments by the member, with how many are theirs.

No committee amendment by this member found this term.

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

National delegation

  • Delegation Malta National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Data version
data version 7669c786bb14 (1 Oct 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved
1 October 2026

Cite as

EU Parl Watch Research (2026). “Roberta METSOLA”. Member record. memberId 118859. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/118859?page=77&scope=all&vscope=all (retrieved 1 October 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/118859. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/118859?format=application%2Fld%2Bjson (CC BY 4.0); data version 7669c786bb14 (1 Oct 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-member-118859,
  author = {{EU Parl Watch Research}},
  title = {{Roberta METSOLA}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/118859?page=77&scope=all&vscope=all}},
  url = {https://news.eu-parl.st-solutions.dev/members/118859?page=77&scope=all&vscope=all},
  urldate = {2026-10-01},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 118859. Official source: https://www.europarl.europa.eu/meps/en/118859. Data: EP Open Data: member record (CC BY 4.0); data version 7669c786bb14 (1 Oct 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}